NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PAREXEL International Corporation (NASDAQ:PRXL) resulting from allegations that PAREXEL may have issued materially misleading business information to the investing public.
On November 10, 2016, during aftermarket hours, PAREXEL disclosed that it is delaying the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2016, because “[o]n November 3, 2016, the Company identified potential errors related to the timing of revenue recognition, almost all related to prior periods, with regard to its Clinical Research Services business segment.” On this news, shares of PAREXEL fell sharply during intraday trading on November 11, 2016.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by PAREXEL investors. If you purchased shares of PAREXEL please visit the firm’s website at http://www.rosenlegal.com/cases-949.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.